Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC)

NCT00919009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

PROCEDURE: TACE (Transcatheter Arterial Chemoembolization )

Sponsor

National Cancer Center, Korea